Study Stopped
RECRUITMENT DIFFICULTIES
Medical Assistance for the Procreation and Risk of Thrombosis.
AMPERT
Assistance Médicale à la Procréation et Risque Thrombotique
1 other identifier
observational
129
1 country
9
Brief Summary
This study aims at evaluating clincal practice regarding prevention of arterial and venous thrombosis following ovarian stimulation. Secondary outcomes are : 1) to describe the incidence and risk factors of arterial and venous thrombosis in women undergoing assisted reproductive technology and 2)to identify the incidence and risk factors for ovarian hyperstimulation syndrome in these women
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2016
Shorter than P25 for all trials
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2015
CompletedFirst Posted
Study publicly available on registry
November 20, 2015
CompletedStudy Start
First participant enrolled
February 2, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2016
CompletedJuly 10, 2020
July 1, 2020
10 months
November 18, 2015
July 8, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of professional clinical practice for ovarian stimulation care
Until 12 months followin ovarian stimulation
Secondary Outcomes (2)
Arterial and/or venous thrombosis
until 12 months following ovarian stimulation
Risk factors for thrombosis
until 12 months following ovarian stimulation
Other Outcomes (1)
Incidence and risk factors for ovarian hyperstimuation syndrome
until 12 months following ovarian stimulation
Study Arms (1)
Women undergoing ART
Observation of the incidence of venous and arterial thrombosis following ovarian stimulation
Interventions
evaluation of clincal practice regarding prevention of arterial and venous thrombosis following ovarian stimulation
Eligibility Criteria
Women undergoing assisted reproductive thechnology
You may qualify if:
- All women undergoing ovarian stimulation in order to receive in vitro fertilization
You may not qualify if:
- Age\<18 years
- Women refusing to particpate in the study
- No health coverage
- Women under guardianship
- Women receiving therapeutic doses of anticoagulation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
Clinique Pasteur
Brest, 29200, France
Medicentre- Clinique du Val d'Ouest
Écully, 69130, France
SELARL Gynecologia
Grenoble, 38000, France
Hôpital Saint Joseph
Marseille, 13001, France
CHU de Nice - Hôpital de l'Archet
Nice, 06202, France
AP-HP - Hôpital Bichat
Paris, 75018, France
Clinique Multualiste La sagesse
Rennes, 35000, France
Clinique Mathilde
Rouen, 76100, France
CHU de Strasbourg - CMCO
Schiltigheine, 67300, France
Biospecimen
One blood sample for each women particpating in the study
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2015
First Posted
November 20, 2015
Study Start
February 2, 2016
Primary Completion
November 20, 2016
Study Completion
November 20, 2016
Last Updated
July 10, 2020
Record last verified: 2020-07